New heteroleptic lanthanide complexes as multimodal drugs: Cytotoxicity studies, apoptosis, cell cycle analysis, DNA interactions, and protein binding. (18th October 2020)
- Record Type:
- Journal Article
- Title:
- New heteroleptic lanthanide complexes as multimodal drugs: Cytotoxicity studies, apoptosis, cell cycle analysis, DNA interactions, and protein binding. (18th October 2020)
- Main Title:
- New heteroleptic lanthanide complexes as multimodal drugs: Cytotoxicity studies, apoptosis, cell cycle analysis, DNA interactions, and protein binding
- Authors:
- Munteanu, Alexandra‐Cristina
Musat, Mihaela Georgiana
Mihaila, Mirela
Badea, Mihaela
Olar, Rodica
Nitulescu, George Mihai
Rădulescu, Flavian Ștefan
Brasoveanu, Lorelei Irina
Uivarosi, Valentina - Abstract:
- Abstract : We report herein the synthesis and characterization of four new heteroleptic complexes of Sm(III), Eu(III), Gd(III), and Tb(III) with the natural flavonoid 5‐hydroxyflavone (primuletin) and 1, 10‐phenanthroline. According to the physicochemical characterization, the mononuclear complexes correspond to the general formula [Ln(OH) 2 L 1 L 2 ]· n H 2 O, where L1 = C15 H9 O3 (deprotonated 5‐hydroxyflavone) and L2 = C12 H8 N2 (1, 10‐phenanthroline), Ln is the lanthanide cation, and n = 4 for Sm(III), 3.5 for Eu(III), 2 for Gd(III), and 3 for Tb(III). A six‐coordinated distorted octahedron geometry was proposed for the complexes, and density functional theory (DFT) studies were used to calculate their optimized geometry. Cytotoxicity was studied using MTS assay on cervical, colorectal, colon, breast, and ovarian adenocarcinoma cell lines. Flow cytometry data were consistent with apoptotic cell death and disruption of the cell cycle in cervical and colon cancer cells. As a means to investigate the mechanism underlying the cytotoxic effects, the abilities of the complexes to interact with calf thymus DNA, human serum albumin, and transferrin have also been assessed. According to experimental and computational studies, the four lanthanide complexes act as DNA intercalators and bind strongly to serum proteins. Abstract : Heteroleptic complexes of Sm(III), Eu(III), Gd(III), and Tb(III) with 5‐hydroxyflavone and 1, 10‐phenanthroline have been synthesized and characterized;Abstract : We report herein the synthesis and characterization of four new heteroleptic complexes of Sm(III), Eu(III), Gd(III), and Tb(III) with the natural flavonoid 5‐hydroxyflavone (primuletin) and 1, 10‐phenanthroline. According to the physicochemical characterization, the mononuclear complexes correspond to the general formula [Ln(OH) 2 L 1 L 2 ]· n H 2 O, where L1 = C15 H9 O3 (deprotonated 5‐hydroxyflavone) and L2 = C12 H8 N2 (1, 10‐phenanthroline), Ln is the lanthanide cation, and n = 4 for Sm(III), 3.5 for Eu(III), 2 for Gd(III), and 3 for Tb(III). A six‐coordinated distorted octahedron geometry was proposed for the complexes, and density functional theory (DFT) studies were used to calculate their optimized geometry. Cytotoxicity was studied using MTS assay on cervical, colorectal, colon, breast, and ovarian adenocarcinoma cell lines. Flow cytometry data were consistent with apoptotic cell death and disruption of the cell cycle in cervical and colon cancer cells. As a means to investigate the mechanism underlying the cytotoxic effects, the abilities of the complexes to interact with calf thymus DNA, human serum albumin, and transferrin have also been assessed. According to experimental and computational studies, the four lanthanide complexes act as DNA intercalators and bind strongly to serum proteins. Abstract : Heteroleptic complexes of Sm(III), Eu(III), Gd(III), and Tb(III) with 5‐hydroxyflavone and 1, 10‐phenanthroline have been synthesized and characterized; DFT studies have been used to calculate their optimized geometry. The complexes were found to be cytotoxic on several cancer cell lines, to induce apoptosis and act as cell cycle modulators in cervix and colon adenocarcinoma cells. All four complexes act as DNA intercalators and bind strongly to serum proteins. … (more)
- Is Part Of:
- Applied organometallic chemistry. Volume 35:Number 1(2021)
- Journal:
- Applied organometallic chemistry
- Issue:
- Volume 35:Number 1(2021)
- Issue Display:
- Volume 35, Issue 1 (2021)
- Year:
- 2021
- Volume:
- 35
- Issue:
- 1
- Issue Sort Value:
- 2021-0035-0001-0000
- Page Start:
- n/a
- Page End:
- n/a
- Publication Date:
- 2020-10-18
- Subjects:
- anticancer -- DNA -- flavonoids -- lanthanide complexes -- serum proteins
Organometallic chemistry -- Periodicals
Organometallic compounds -- Periodicals
547.05 - Journal URLs:
- http://www3.interscience.wiley.com/cgi-bin/jhome/109566206 ↗
http://www3.interscience.wiley.com/cgi-bin/jhome/2676 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/aoc.6062 ↗
- Languages:
- English
- ISSNs:
- 0268-2605
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 1576.270000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 15345.xml